BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

771 related articles for article (PubMed ID: 29378311)

  • 1. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R; Lauwers GY; Choi WT
    J Crohns Colitis; 2022 Dec; 16(12):1825-1834. PubMed ID: 35771958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
    J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
    Axelrad JE; Faye A; Slaughter JC; Harpaz N; Itzkowitz SH; Shah SC
    Inflamm Bowel Dis; 2022 Jun; 28(6):855-861. PubMed ID: 34319381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
    Mahmoud R; Shah SC; Torres J; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Harpaz N; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1518-1527.e3. PubMed ID: 31446183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
    Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Ricciuto A; Fish J; Carman N; Walters TD; Church PC; Hansen BE; Crowley E; Siddiqui I; Nguyen GC; Kamath BM; Griffiths AM
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1098-1105.e1. PubMed ID: 29378308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Imam MH; Thackeray EW; Lindor KD
    Colorectal Dis; 2013 Feb; 15(2):198-203. PubMed ID: 22712545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
    De Jong ME; Van Tilburg SB; Nissen LHC; Kievit W; Nagtegaal ID; Horjus CS; Römkens TEH; Drenth JPH; Hoentjen F; Derikx LAAP
    J Crohns Colitis; 2019 Dec; 13(12):1485-1491. PubMed ID: 31175827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA content abnormality frequently develops in the right/proximal colon in patients with primary sclerosing cholangitis and inflammatory bowel disease and is highly predictive of subsequent detection of dysplasia.
    Zhang R; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
    Histopathology; 2023 Jul; 83(1):116-125. PubMed ID: 37012656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
    Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
    Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
    Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
    [No Abstract]   [Full Text] [Related]  

  • 17. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Torres J; Pineton de Chambrun G; Itzkowitz S; Sachar DB; Colombel JF
    Aliment Pharmacol Ther; 2011 Sep; 34(5):497-508. PubMed ID: 21692821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis.
    Broomé U; Löfberg R; Lundqvist K; Veress B
    Dis Colon Rectum; 1995 Dec; 38(12):1301-5. PubMed ID: 7497843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
    Pekow JR; Hetzel JT; Rothe JA; Hanauer SB; Turner JR; Hart J; Noffsinger A; Huo D; Rubin DT
    Inflamm Bowel Dis; 2010 Aug; 16(8):1352-6. PubMed ID: 20027656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review with meta-analysis: incidence and factors for progression to advanced neoplasia in inflammatory bowel disease patients with indefinite and low-grade dysplasia.
    Wan J; Wang X; Zhang Y; Chen M; Wang M; Wu K; Liang J
    Aliment Pharmacol Ther; 2022 Mar; 55(6):632-644. PubMed ID: 35166389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.